Medical Exoskeleton Market: Global Industry Analysis and Forecast (2022-2029)

Medical Exoskeleton Market was valued at US$ 0.2 Bn. in 2021. Global Medical Exoskeleton Market size is expected to grow at a CAGR of 36.2 % through the forecast period.

Medical Exoskeleton Market Overview:

A wearable electromechanical device known as a medical exoskeleton was created to help patients with mobility difficulties recover from their injuries and motor function in their partly or fully paralyzed lower extremities. The gadgets can improve biological abilities, such as orthotics devices that help people regain their ability to walk or move. This wearable gadget thereby allows patients more mobility, strength, and endurance. People with physical disabilities including spinal cord injuries, neurological disorders, paralysis, or elderly individuals live better due to medical exoskeletons.Global Medical Exoskeleton MarketTo know about the Research Methodology:-Request Free Sample Report Some of the medical exoskeletons are used in physiotherapy and rehabilitation facilities for inpatient treatment and mobility. This technology is also used by other sectors, including the military and citizens, to increase soldier mobility and cargo capacity as well as load handling skills. The gadget is used in the medical field to teach patients with motor nerve degradation and cognitive-motor limitations as well as to restore lost capability and prolong patient life. 2021 is considered as a base year to forecast the market from 2022 to 2029. 2021’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2029. 2021 is a year of exception and analysis especially with the impact of lockdown by region.

Medical Exoskeleton Market Dynamics:

Market Drivers: Affordable exoskeleton with improved sensory systems with numerous degrees of flexibility: In order to accomplish effective parallel control, the rapid improvements in robotics & virtual reality need more complicated human-machine interfaces. The exoskeleton is just wearable equipment that costs a lot of money and requires a lot of data processing to capture multidimensional human actions. A triboelectric bi-directional sensor, as an alternative to a specialized exoskeleton, can monitor all of the moveable joints in the human upper limbs with the least amount of power. The virtual character and robotic arms are controlled in real-time using the matching movements, which comprise two degrees of freedom (DOF) shoulders revolutions, wrist-twisting, and bending motions. Due to the structural similarity between the exoskeleton as well as the human body, the following kinetic analysis provides additional physical characteristics without the need for extra sensors. A high-tech, low-cost human-machine interface for handling items in the physical and virtual worlds, such as in robotic process automation, healthcare, and training, holds great potential for this exoskeleton sensory system. As a result of the above factors, the sector is expected to lead during the forecast period. Growing need for orthopedic rehabilitation in the healthcare market: In addition to other variables, such as an aging population, an increase in road accidents & severe trauma injuries, and an increase in the frequency of stroke, the number of persons with physical impairments is rising globally. Exoskeletons for rehabilitation are used to help patients recover from serious physical injuries or to aid them with normal tasks. According to MMR, more than 2,95,000 Americans suffer serious spinal injuries each year. Paraplegia strikes about 54% of these people. The National Center for Biotechnology Information (NCBI) estimates that there were 2.1 million persons living with limb loss in the United States in 2017 and that this figure will double by 2050. To assist patients suffering from a stroke or other diseases, many important players are developing exoskeletons for orthopedic rehabilitation. Rising stroke incidences: One of the most common causes of acquired severe disability, stroke has a higher chance of surviving as medical science and treatment methods advance. Rehab treatment methods would be required due to the region's aging population, which is susceptible to strokes & mobility problems. Exoskeleton demand is rising as a result of an aging population with stroke-related impairments and people who have trouble communicating and moving. Market Restraints: Difficulties in obtaining regulatory approvals for exoskeleton medical applications: The key concerns in the advancement of medical devices are user safe and device reliability. Manufacturers' technical design skills and knowledge are critical during product testing. Because a medical equipment failure might be harmful, exoskeletons used for healthcare reasons must be properly reviewed. Also, only a few standards now apply directly to the exoskeleton sector. Only items that have acquired FDA approval can be offered to clients, and the FDA accepts ISO standards which can apply to relevant firms. According to reports released on September 29, 2020, the European Parliament has passed strict resolutions prohibiting the direct use of automation and artificial intelligence, emphasizing the reason that contact is expected to generate several ethical, legal, and social difficulties. Market Trends: In March 2021, At the Hannover Messe Digital Edition 2021 event, Ottobock introduced the Paexo Shoulder Jacket, Paexo Thumb Slim, and Paexo Cool Sleeve products. During strenuous duties like moving heavy packages or performing overhead labor, these devices provide the body with excellent relaxation. In August 2020, A leading provider of exoskeleton technologies for medical and industrial applications, Ekso Bionics Holdings Inc., launched EVOTM, an upper-body assistance exoskeleton that increases endurance and lessens the strain of repetitive work. The next development in industrial exoskeleton technology is EVO, which builds on the company's ground-breaking EksoVest technology. Medical Exoskeleton Market COVID-19 Insights: The market benefited from the COVID-19 epidemic. The pandemic has had serious effects on clinical management, such as rationing of care as well as the incapability of ICUs to sustain a high percentage of patients on ventilators during the spike due to a lack of resources and facilities. The pandemic has put a huge strain on health systems as never before. Prone positioning (PP), or turning a patient from the supine position to the prone position, has been demonstrated to improve oxygenation & ventilatory mechanics in ARDS patients who need mechanical ventilation support. As a result, PP was frequently used during the COVID-19 epidemic. For example, the ICU at Nancy Hospital performed 116 PP operations in the first 10 days of the epidemic, which is about the same as how many operations they typically carry out in a calendar year. The prone placement of ventilated patients COVID-19 patients with the use of exoskeletons.

Medical Exoskeleton Market Segment Analysis:

Based on Type, the powered segment dominated the market with 57% share in 2021.The rising demand for personal safety and performance, as well as the existence of multiple controlling features and sensors to monitor tilt, speed, and motion, are major drivers of the growth of this segment. The increasing usage by construction personnel to move large things is likely to support the growth of this market. The existence of various regulating functions and sensors in this type of exoskeletons to measure tilt, speed, and motion is also boosting the segment's growth. The passive exoskeleton segment will be at a fast rate as a result of its affordability and lighter weight.Medical Exoskeleton Market Based on the Extremity, the lower extremity Medical Exoskeletons segment dominated the market with 42% share in 2021. This can be attributed to their benefits, such as a rise in neurological injuries, which can lead to significant muscle weakness as well as impaired motor control, severely affecting individuals' gait and motion abilities. Another important factor driving the increased need for lower extremity exoskeletons is orthopedic rehabilitation training, which typically entails performing certain motions to induce motor plasticity and, eventually, better motor recovery. Patients must develop their musculoskeletal power and motor control while minimizing functional limitations.

Medical Exoskeleton Market Regional Insights:

The North America region dominated the market with 34% % share in 2021. This is because of the rising geriatric population, increased incidence of strokes as well as traumatic brain injuries, rising prevalence of neurological disorders, and increasing government focus on providing access to health care services to such indications all assisted market growth in this region. The increased occurrence of spinal cord injury is one of the key causes driving the expansion of exoskeletons in this region The Asia Pacific region is expected to witness significant growth at a CAGR of 39.1% through the forecast period. Rapid population growth and rising economic development are driving the expansion of this area in the exoskeleton industry. Countries in this area, such as China, and India are some of the most technologically growing in the world, giving significant potential opportunities for market players. The objective of the report is to present a comprehensive analysis of the global Medical Exoskeleton Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Medical Exoskeleton Market dynamic, structure by analyzing the market segments and projecting the Medical Exoskeleton Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Medical Exoskeleton Market make the report investor’s guide.

Medical Exoskeleton Market Scope: Inquire before buying

Global Medical Exoskeleton Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US$ 0.2 Bn.
Forecast Period 2022 to 2029 CAGR: 36.2% Market Size in 2029: US$ 2.36 Bn.
Segments Covered: by Type • Powered Exoskeletons • Passive Exoskeletons
by Extremity • Upper Extremity Medical Exoskeletons • Lower Extremity Medical Exoskeletons • Full Body

Medical Exoskeleton Market by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Medical Exoskeleton Market Key Players are:

ReWalk Robotics Ltd. (Israel) • Lockheed Martin Corporation (U.S.) • Parker Hannifin Corporation (U.S.) • Ekso Bionics Holdings, Inc. (U.S.) • Hyundai Motor Company (South Korea) • Bionik Laboratories Corporation (U.S.) • Myomo, Inc. (U.S.) • Honda Motor Co. Ltd. (Japan) • Technaid. S.L. (Spain) • Gogoa Mobility Robots SL (Spain) • Suitx Inc. (U.S.) • Otto Bock HealthCare GmbH (Germany) • Wearable Robotics SRL (Italy) • DIH Technologies Corporation (Switzerland) Frequently Asked Questions: 1] What segments are covered in the Global Medical Exoskeleton Market report? Ans. The segments covered in the Medical Exoskeleton Market report are based on Product Type, Extremity and geography. 2] Which region is expected to hold the highest share in the Global Medical Exoskeleton Market? Ans. The North America region is expected to hold the highest share in the Medical Exoskeleton Market. 3] What is the market size of the Global Medical Exoskeleton Market by 2029? Ans. The market size of the Medical Exoskeleton Market by 2029 is expected to reach US$ 2.36 Bn. 4] What is the forecast period for the Global Medical Exoskeleton Market? Ans. The forecast period for the Medical Exoskeleton Market is 2022-2029. 5] What was the market size of the Global Medical Exoskeleton Market in 2021? Ans. The market size of the Medical Exoskeleton Market in 2021 was valued at US$ 0.2 Bn.
1. Global Medical Exoskeleton Market Size: Research Methodology 2. Global Medical Exoskeleton Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Medical Exoskeleton Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Medical Exoskeleton Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Medical Exoskeleton Market Size Segmentation 4.1. Global Medical Exoskeleton Market Size, by Type (2021-2029) • Powered Exoskeletons • Passive Exoskeletons 4.2. Global Medical Exoskeleton Market Size, by Extremity (2021-2029) • Upper Extremity Medical Exoskeletons • Lower Extremity Medical Exoskeletons • Full Body 5. North America Medical Exoskeleton Market (2021-2029) 5.1. North America Medical Exoskeleton Market Size, by Type (2021-2029) • Powered Exoskeletons • Passive Exoskeletons 5.2. North America Medical Exoskeleton Market Size, by Extremity (2021-2029) • Upper Extremity Medical Exoskeletons • Lower Extremity Medical Exoskeletons • Full Body 5.3. North America Medical Exoskeleton Market, by Country (2021-2029) • United States • Canada • Mexico 6. Europe Medical Exoskeleton Market (2021-2029) 6.1. Europe Medical Exoskeleton Market, by Type (2021-2029) 6.2. Europe Medical Exoskeleton Market, by Extremity (2021-2029) 6.3. Europe Medical Exoskeleton Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Medical Exoskeleton Market (2021-2029) 7.1. Asia Pacific Medical Exoskeleton Market, by Type (2021-2029) 7.2. Asia Pacific Medical Exoskeleton Market, by Extremity (2021-2029) 7.3. Asia Pacific Medical Exoskeleton Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Medical Exoskeleton Market (2021-2029) 8.1. Middle East and Africa Medical Exoskeleton Market, by Type (2021-2029) 8.2. Middle East and Africa Medical Exoskeleton Market, by Extremity (2021-2029) 8.3. Middle East and Africa Medical Exoskeleton Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Medical Exoskeleton Market (2021-2029) 9.1. South America Medical Exoskeleton Market, by Type (2021-2029) 9.2. South America Medical Exoskeleton Market, by Extremity (2021-2029) 9.3. South America Medical Exoskeleton Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. ReWalk Robotics Ltd. (Israel) 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Lockheed Martin Corporation (U.S.) 10.3. Parker Hannifin Corporation (U.S.) 10.4. Ekso Bionics Holdings, Inc. (U.S.) 10.5. Hyundai Motor Company (South Korea) 10.6. Bionik Laboratories Corporation (U.S.) 10.7. Myomo, Inc. (U.S.) 10.8. Honda Motor Co. Ltd. (Japan) 10.9. Technaid. S.L. (Spain) 10.10. Gogoa Mobility Robots SL (Spain) 10.11. Suitx Inc. (U.S.) 10.12. Otto Bock HealthCare GmbH (Germany) 10.13. Wearable Robotics SRL (Italy) 10.14. DIH Technologies Corporation (Switzerland)